Third FDA acceptance of a lifespan extension drug. Solo founded

Press Space to continue

Third FDA acceptance of a lifespan extension drug. Solo founded in 2019. Go Loyal!

When we started Loyal there was no FDA pathway for a any lifespan extension drug. Today the FDA accepted our third one! LOY-003, our daily pill for helping large dogs live longer (and healthier) lives, has earned RXE efficacy approval. https://t.co/bqAIXdiBro